Patent ID: 8535896

Claim:
A method for the diagnosis of inflammation of the liver, comprising the step of determining the concentration of at least one protein selected from (a) the group consisting of ER60, vimentin, actin alpha 1 skeletal muscle protein, hMFAP 4, tropomyosin, PTGES 2, amyloid P-component, transgelin, calponin 1, Homo sapiens p20 protein, 17 kDa myosin light chain, H chain H IgG B12, prolyl 4-hydroxylase beta subunit, and (b) the group consisting of methylene tetrahydrofolate dehydrogenase 1, PRO2619, aldehyde dehydrogenase 1, fibrinogen alpha-chain preproprotein, fructose-bisphosphate-aldolase B, argininosuccinate synthetase, EEF1A2, ATP5A1, alpha-2-actin, regucalcin, serum albumin, mitochondrial malate dehydrogenase, and mitochondrial acetoacetyl-CoA thiolase, in a sample from a human patient, wherein a concentration of said at least one protein in said sample from group (a) which is elevated in relation to the healthy state indicates the presence of an inflammation of the liver; and wherein a concentration of said at least one protein in said sample from group (b) which is decreased in relation to the healthy state indicates the presence of an inflammation of the liver.